Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
暂无分享，去创建一个
C. Stief | J. Schalken | B. Schmitz-Dräger | D. Hessels | M. Ferro | Á. Borque-Fernando | V. Vlaeminck-Guillem | J. Sedelaar | T. Govers | W. van Criekinge | C. Martínez-Ballesteros | J. Rubio-Briones | Á. Borque‐Fernando | J. Schalken | Bernd J. Schmitz-Dräger | Christian G. Stief | J. Sedelaar